載入...
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
BACKGROUND: First- and second-generation smallpox vaccines are contraindicated in individuals infected with human immunodeficiency virus (HIV). A new smallpox vaccine is needed to protect this population in the context of biodefense preparedness. The focus of this study was to compare the safety and...
Na minha lista:
發表在: | Open Forum Infect Dis |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Oxford University Press
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4567089/ https://ncbi.nlm.nih.gov/pubmed/26380340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofv040 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|